BenevolentBio’s artificial intelligence could discover a better treatment for ALS

jackie-hunter-benevolentbio What if the drug that could effectively treat amyotrophic lateral sclerosis, the paralyzing neurological disease that skyrocketed into the public consciousness thanks to the ice bucket challenge, already exists? That’s the question confronting Jackie Hunter, CEO of BenevolentBio. Hunter runs the biomedical arm of the artificial intelligence firm BenevolentAI, applying machine learning… Read More

from TechCrunch


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s